The 86 references in paper G. Baymakanova E., S. Avdeev N., Г. Баймаканова Е., С. Авдеев Н. (2014) “Диагностическая и прогностическая роль повышения биомаркеров повреждения миокарда (тропонина I и белка, связывающего жирные кислоты) при обострении хронической обструктивной болезни легких // Diagnostic and prognostic impact of heart injury biomarkers (troponin I and heart-type fatty acid binding protein) in patient with acute exacerbations of chronic obstructive pulmonary disease” / spz:neicon:pulmonology:y:2012:i:1:p:66-74

1
McGhan R., Radcliff T., Fish R. et al. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007; 132: 1748–1755.
(check this in PDF content)
2
Ruiz-Gonzalez A., Lacasta D., Ibarz M. et al. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease. Respirology 2008; 13: 1028–1033.
(check this in PDF content)
3
Sin D.D., Anthonisen N.R., Soriano J.B., Agusti A.G. Mortality in COPD: role of comorbidities. Eur. Respir. J. 2006; 28: 1245–1257.
(check this in PDF content)
4
Holguin F., Folch E., Redd S.C. et al.Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979–2001. Chest 2005; 128: 2005–2011.
(check this in PDF content)
5
Connors A.F.Jr., Dawson N.V., Thomas C. et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 1996, 154: 959–967.
(check this in PDF content)
6
Pingleton S.K. Complications of acute respiratory failure. Am. Rev. Respir. Dis. 1988; 137: 1463–1493.
(check this in PDF content)
7
Kollef M.H., Ladenson J.H., Eisenberg P.R. Clinically recognized cardiac dysfunction: an independent determinant of mortality among critically ill patients. Is there a role for serial measurement of cardiac troponin I? Chest 1997; 111: 1340–1347.
(check this in PDF content)
8
Guest T.M., Ramanathan A.V., Tuteur P.G. et al. Myocardial injury in critically ill patients. A frequently unrecognized complication. J.A.M.A. 1995; 273: 1945–1949.
(check this in PDF content)
9
Render M.L., Weinstein A.S., Blaustein A.S. Left ventricular dysfunction in deteriorating patients with chronic obstructive pulmonary disease. Chest 1995; 107: 162–168.
(check this in PDF content)
10
Thygesen K., Alpert J.S., White H.D.Universal definition of myocardial infarction. J. Am. Coll. Cardiol. 2007; 50 (22): 2174–2195.
(check this in PDF content)
11
Adams J.E. III, Bodor G., Davila-Roman V. et al.Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993; 88 (1): 101–106.
(check this in PDF content)
12
Missov E., Calzolari C., Pau B.Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997; 96: 2953–2958.
(check this in PDF content)
13
Meyer T., Binder L., Hruska N. et al.Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J. Am. Coll. Cardiol. 2000; 36: 1632–1636.
(check this in PDF content)
14
Apple F.S., Murakami M.M., Pearce L.A. et al. Predictive value of cardiac troponin I and T for subsequent death in endstage renal disease. Circulation 2002. 106 (23): 2941–2945.
(check this in PDF content)
15
Kang E.W., Na H.J., Hong S.M. et al.Prognostic value of elevated cardiac troponin I in ESRD patients with sepsis. Nephrol. Dial. Transplant. 2009; 24 (5): 1568–1573.
(check this in PDF content)
16
Baillard C., Boussarssar M., Fosse J.P. et al.Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intens. Care Med. 2003; 29: 584–589.
(check this in PDF content)
17
King D.A., Codish S., Novack V. et al. The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit. Care 2005; 9 (4): 31.
(check this in PDF content)
18
Kollef M.H., Ladenson J.H., Eisenberg P.R.Clinically recognized cardiac dysfunction: an independent determinant of mortality among critically ill patients. Chest 1997; 111 (5): 1340–1347. Оригинальные исследования
(check this in PDF content)
19
Noble J., Reid A., Jordan L. et al. Troponin I and myocardial injury in the ICU. Br. J. Anaesth. 1999; 82: 41–46.
(check this in PDF content)
20
Relos R.P., Hasinoff I.K., Beilman G.J. Moderately elevated serum troponin concentrations are associated with increased morbidity and mortality rates in surgical intensive care unit patients. Crit. Care Med. 2003; 31 (11): 2598–2603.
(check this in PDF content)
21
Turley A.J., Gedney J.A.Role of cardiac troponin as a prognosticator in critically ill patients. Crit. Care 2005; 9 (6): E30.
(check this in PDF content)
22
Wright R.S., Williams B.A., Cramner H. et al.Elevations of cardiac troponin I are associated with increased short-term mortality in noncardiac critically ill emergency department patients. Am. J. Cardiol. 2002; 90 (6): 634–636.
(check this in PDF content)
23
Babuin L., Vasile V.C., Rio Perez J.A. et al. Elevated cardiac troponin is an independent risk factor for short- and longterm mortality in medical intensive care unit patients. Crit. Care Med. 2008; 36 (3): 759–765.
(check this in PDF content)
24
Quenot J.P., Le Teuff G., Quantin C. et al.Myocardial injury in critically ill patients. Chest 2005; 128 (4): 2758–2764.
(check this in PDF content)
25
Ammann P., Maggiorini M., Bertel O. et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J. Am. Coll. Cardiol. 2003; 41: 2004–2009.
(check this in PDF content)
26
Chan C.P., Sum K.W., Cheung K.Y. et al.Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein. J. Immunol. Meth. 2003; 279 (1/2): 91–100.
(check this in PDF content)
27
Panteghini M. Role and importance of biochemical markers in clinical cardiology. Eur. Heart J. 2004; 25: 1187–1196.
(check this in PDF content)
28
Mad P., Domanovits H., Fazelnia C. et al.Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. Quart. J. Med. 2007; 100: 203–210.
(check this in PDF content)
29
O'Donoghue M., de Lemos J.A., Morrow D.A. et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 2006; 114: 550–557.
(check this in PDF content)
30
Kilcullen N., Viswanathan K., Das R. et al.Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J. Am. Coll. Cardiol. 2007; 50: 2061–2067.
(check this in PDF content)
31
Niizeki T., Takeishi Y., Arimoto T. et al. Persistently increased serum concentration of heart-type fatty-acidbinding protein predicts adverse clinical outcomes in patients with chronic heart failure. Circ. J. 2008; 72: 109–114.
(check this in PDF content)
32
Lankeit M., Dellas C., Panzenböck A. et al.Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2008; 31: 1024–1029.
(check this in PDF content)
33
Puls M., Dellas C., Lankeit M. et al. Heart-type fatty acid binding protein permits early risk stratification of pulmonary embolism. Eur. Heart J. 2007; 28: 224–229.
(check this in PDF content)
34
Oktay B., Ardic S. Is heart type fatty acid binding protein a marker of cardiac damage in patients with acute attacks of chronic obstructive pulmonary disease? Eur. Respir. J. 2009; Р3111; 103s.
(check this in PDF content)
35
Seyhan E.C., Onur I., Sokucu S. et al.Relation of troponin and hert type fatty acid protein (H-FABP) levels to echocardiographic and cardiac infarction injury score (CIS) with patients with prespiratory insufficiency due to COPD attack. Eur. Respir. J. 2009; Р695; 123s.
(check this in PDF content)
36
Brekke P.H., Omland T., Holmedal S.H. et al.Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation. Eur. Respir. J. 2008; 31: 563–570.
(check this in PDF content)
37
Martins C.S., Rodrigues M.J.O., Miranda V.P., Nunes J.P.L. Prognostic value of cardiac troponin I in patients with COPD acute exacerbation. Netherlands J. Med. 2009; 67 (10): 341–349.
(check this in PDF content)
38
Chang C.L., Robinson S.C., Mills G.D. et al.Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax 2011; 66 (9): 764–768.
(check this in PDF content)
39
Global Initiative for Chronic Obstructive Lung Disease GOLD. Global Strategy for the Diagnosis, Management, and Preventionof Chronic Obstructive Pulmonary Disease. 2009. http://www.goldcopd.com (accessed 27 Jun. 2010).
(check this in PDF content)
40
Anthonisen N.R., Manfreda J., Warren C.P. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106: 196–204.
(check this in PDF content)
41
Quanier P.H., Tammeling G.J., Cotes J.E. et al.Lung volumes and forced ventilatory flows. Eur. Respir. J. 1993; 6 (Suppl. 16): 5–40.
(check this in PDF content)
42
Swedberg K., Cleland J., Dargie H. et al.The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur. Heart J. 2005; 26: 1115–1140.
(check this in PDF content)
43
Cheng V., Kazanagra R., Garcia A. et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J. Am. Coll. Cardiol. 2001; 37: 386–391.
(check this in PDF content)
44
Joint ESC / ACCF / AHA / WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007; 27; 116: 26–34.
(check this in PDF content)
45
Korff S., Katus H.A., Giannitsis E.Differential diagnosis of elevated troponins. Heart 2006; 92: 987–993.
(check this in PDF content)
46
Torbicki A., Kurzyna M., Kuca P. et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003; 108: 844–848.
(check this in PDF content)
47
Barnes P.J. Chronic obstructive fulmonary disease. N. Engl. J. Med. 2000; 343: 269–280.
(check this in PDF content)
48
Wouters E.F.M.Local and systemic inflammation in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005; 2: 26–33.
(check this in PDF content)
49
Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005; 352: 1685–1695.
(check this in PDF content)
50
Fabbri L.M., Rabe K.F.From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370: 797–799.
(check this in PDF content)
51
Donaldson G.C., Hurst J.R., Smith C.J. et al.Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 2010; 137: 1091–1097.
(check this in PDF content)
52
Antman E.M., Tanasijevic M.J., Thompson B. et al. Cardiacspecific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N. Engl. J. Med. 1996; 335: 1342–1349.
(check this in PDF content)
53
Jeremias A., Gibson M. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann. Intern. Med. 2005; 142: 786–791.
(check this in PDF content)
54
Higgins J.P., Higgins J.A.Elevation of cardiac troponin I indicates more than myocardial ischemia. Clin. Invest. Med. 2003; 26: 133–147.
(check this in PDF content)
55
Meyer T., Binder L., Hruska N. et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J. Am. Coll. Cardiol. 2000; 36: 1632–1636.
(check this in PDF content)
56
Mahajan N., Mehta Y., Rose M. et al.Elevated troponin level is not synonymous with myocardial infarction. Int. J. Cardiol. 2006; 111: 442–449. Баймаканова Г.Е., Авдеев С.Н.Диагностическая и прогностическая роль повышения биомаркеров повреждения миокарда
(check this in PDF content)
57
Nunes J.P.L., Macedo F. An analytical triad for the diagnosis of pulmonary embolism. Cardiology 2000; 94: 264.
(check this in PDF content)
58
Hessel M.H.M., Atsma D.E., van der Valk E.J.M. et al. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch. Eur. J. Physiol. 2008; 455: 979–986.
(check this in PDF content)
59
Feng J., Schaus B.J., Fallavollita J.A. et al.Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2001; 103: 2035–2037.
(check this in PDF content)
60
Peacock W.F., De Marco T., Fonarow G.C. et al. Cardiac troponin I and outcome in acute heart failure. N. Engl. J. Med. 2008; 358: 2117–2126.
(check this in PDF content)
61
Abroug F., Ouanes-Besbes L., Nciri N. et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am. J. Respir. Crit. Care Med. 2006; 174: 990–996.
(check this in PDF content)
62
Le Jemtel T., Padeletti M., Jelic S.Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J. Am. Coll. Cardiol. 2007; 49 (2): 171–180.
(check this in PDF content)
63
Brueckmann M., Huhle G., Lang S. et al.Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005; 112 (4): 527–534.
(check this in PDF content)
64
Roch A., Allardet-Servent J., Michelet P. et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit. Care Med. 2005; 33: 1001–1007.
(check this in PDF content)
65
Charpentier J., Luyt C.-E., Fulla Y. et al. Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit. Care Med. 2004; 32: 660–665.
(check this in PDF content)
66
Hoffmann U., Brueckmann M., Bertsch T. et al. Increased plasma levels of NT-proANP and NTproBNP as markers of cardiac dysfunction in septic patients. Clin. Lab. 2005; 51: 373–379.
(check this in PDF content)
67
Berendes E., Van Aken H., Raufhake C. et al. Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth. Analg. 2001; 93: 676–682.
(check this in PDF content)
68
Cuthbertson B.H., Patel R.R., Croal B.L. et al.B-type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia 2005; 60: 16–21.
(check this in PDF content)
69
Jefic D., Lee J.W., Jefic D. et al. Utility of B-type natriuretic peptide and N-terminal pro Btype natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest 2005; 128: 288–295.
(check this in PDF content)
70
Rudiger A., Gasser S., Fischler M. et al.Comparable increase of B-type natriuretic peptide and amino-terminal pro-Btype natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit. Care Med. 2006; 34: 2140–2144.
(check this in PDF content)
71
Chien J.-Y., Lin V.-S., Huang Y.-C. T. et al. Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial. Crit. Care Med. 2008; 36 (5): 1421–1426.
(check this in PDF content)
72
Christ M., Thuerlimann A., Laule K. et al. Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea. Eur. J. Clin. Invest. 2007; 37: 834–841.
(check this in PDF content)
73
Mueller T., Gegenhuber A., Poelz W. et al. Head-to-head comparison of the diagnostic utility of BNP and NTproBNP in symptomatic and asymptomatic structural heart disease. Clin. Chim. Acta 2004; 341: 41–48.
(check this in PDF content)
74
Nagaya N., Nishikimi T., Uematsu M. et al.Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000; 102: 865–870.
(check this in PDF content)
75
Stolz D., Breidthardt N., Christ-Crain M. et al. Use of B-Type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest 2008; 133 (5): 1088–1094.
(check this in PDF content)
76
Glatz J.F., van Bilsen M., Paulussen R.J. et al. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim. Biophys. Acta. 1988; 961 (1): 148–152.
(check this in PDF content)
77
Seino Y., Ogata K., Takano T. et al. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am. J. Med. 2003; 115 (3): 185–190.
(check this in PDF content)
78
Reichlin T., Hochholzer W., Bassetti S. et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J Med. 2009; 361 (9): 858–867.
(check this in PDF content)
79
Valle H.A., Riesgo L.G., Bel M.S. et al.Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome. Eur. J. Emerg. Med. 2008; 15 (3): 140–144.
(check this in PDF content)
80
Haltern G., Peiniger S., Bufe A. et al. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. Am. J. Cardiol. 2010; 105 (1): 1–9.
(check this in PDF content)
81
McCann C.J., Glover B.M., Menown I.B. et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur. Heart J. 2008; 29 (23): 2843–2850.
(check this in PDF content)
82
O'Donoghue M., de Lemos J.A., Morrow D.A. et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 2006; 114 (6): 550–557.
(check this in PDF content)
83
Kilcullen N., Viswanathan K., Das R. et al.Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J. Am. Coll. Cardiol. 2007; 50: 2061–2067.
(check this in PDF content)
84
Vuilleumier N., Le Gal G., Verschuren F. et al. Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study. J. Thromb. Haemost. 2009; 7: 391–398.
(check this in PDF content)
85
Kaczynska A., Pelsers M.M., Bochowicz A. et al. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin. Chim. Acta 2006; 371: 117–123.
(check this in PDF content)
86
Yan G.T., Lin J., Hao X.H. et al.Heart-type fatty acid-binding protein is a useful marker for organ dysfunction and leptin alleviates sepsis-induced organ injuries by restraining its tissue levels. Eur. J. Pharmacol. 2009; 616 (1–3): 244–250. Информация об авторах
(check this in PDF content)